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ABSTRACT  
Objectives 
To evaluate modifications of gut microbiota after antibiotic therapy in breastfed infants. 
Study design 
We recruited 26 exclusively breastfed infants younger than 5 months hospitalized for pneumonia 
and treated with ceftriaxone (at dosage of 50 mg per kilo per day  administred intramuscularly) 
were recruited. and we analyzed Iintestinal microbiota at day 0 - before starting antibiotic 
administration - at the end of the therapy (5 days after) and after 15 days after the stop was 
analyzed.   
Stool samples were collected and immediatly diluted and cultured on several selective media to 
detect total bacteria, Enterobacteriaceae, eEnterococci  and lLactobacilli. Statistical analysis was 
performed by using Wilcoxon test. 
Results 
After 5 days of antibiotic therapy we observed a significant reduction in total fecal bacterial count 
(p  = 0.003) and in faecal concentration of Enterobacteriaceae (p = 0.001), Enterococci (p = 0.000) 
and Lactobacilli load (p = 0.000), in comparison with control group at day 0. Conversely, 
The values of bacterial count values for all the speciesbacteria detected after 15 days from the end 
of therapy are significantly increased and similar to control group counts..  
Conclusion 
Our findings showed that gut microbiota was significantly changes modified 5 after antibiotic 
therapy; exclusively breastfeeding  may be relevant in promoting the re-establishment of gut 
microbiota composition in early infancy.
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BACKGROUND 
At birth, the gut is sterile and within few hours, bacteria start to appear in the feces (I-II). The first 
bacteria colonizing the neonatal gut are aerobic or facultatively anaerobic, like such as 
Enterobacteriaceae, eEnterococci and sStaphylococci (III). During their growth they They consume 
oxygen making the intestinal milieu suitable for the proliferation of anaerobic species such as: 
Bifidobacteriumaspp., Clostridium spp.a and Bacteroides spp. (IV).  Type of delivery influences 
gut microbiota Iin the first period of life: maternal faecal and vaginal maternal bacteria colonized 
infants born by spontaneous delivery, whereas infants born through caesarean section are exposed 
to bacteria microorganisms originating from hospital environment and health care workers. 
Intestinal bacterial microbial composition is influenced by gestational age, hygiene measures and 
environmental factors and in the first days of life and type of feeding practices; in particular, breast 
fed infants are less colonized by Clostridium difficile and Escherichia coli than formula fed infants 
(V, VI). Intestinal bacterial composition is also influenced by Antibiotics antibiotic  therapy can that 
could also influence the composition of faecal microbiota with different effects depending on 
antibacterial class, specific spectrum of the agent, dose, route of administration, pharmacokinetic 
and pharmacodynamic properties. Antibiotics are designed to attack specific bacterial pathogens 
but, in the process, they indiscreetely reduce the number of beneficial human microbiota 
microorganisms that, particularly in infants, is and part of the gut-associated lymphatic tissue, 
particularly in infants (A). Studies investigating microbiota modifications induced by antibiotic 
therapy are still limited and mainly performed in adults (VII). In particular, no literature data are 
available in literature on bacterial changes after administration of parenteral ceftriaxone, one of the 
main 3rd generation chepalosporin used in infancy. 
 
AIM 
This study was performed to evaluate both modifications occurring in intestinal microbiota in 
infancy after ceftriaxone antibiotic therapy with ceftriaxone and to evaluatethe  re-estabilishment of 
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the gut microbiota within 2 weeks after treatment in exclusively breastfed infants. For this reason 
we analyze gut microflora before starting antibiotic therapy (T0), after 5 days of drug 
administration (T5) and 15 days later (T20).  
  
MATERIALS AND METHODS  
Study group and patients selection 
26 infants, affected by pneumonia and treated with parenteral ceftriaxone, were recruited in by the 
Department of Paediatrics (Regina Margherita Children Hospital, Turin, Italy). They were all born 
at term, adequate for gestational age, with a birth weight between 2500 and 4000 g, exclusively 
breastfed, aged < 6 months and affected by pneumonia. Infants were excluded if they had clinical 
evidence of gastrointestinal disorders or if they had received other antibiotics or probiotics in the 
week preceding recruitment. 
Parents gave written consent to the inclusion of their infants in the study. The study was approved 
by the local ethicals committee approved the study.  
Study Design and Sample Collection 
All enrolled infants received parenteral ceftriaxone 50 mg/Kg per day for 5 days for pneumonia 
treatment. 
Stool samples were collected from each infant before starting antibiotic therapy (T0 = day of 
hospital admission), after 5 days of drug administration (T5 = the last day of antibiotic therapy) and 
day 20 (T20= 15 days after the end of antibiotic therapy). 
on day 0 (day of hospital admission, before starting antimicrobial treatment), day 5 (the last day of 
antibiotic therapy) and day 20 (15 days after the end of antibiotic therapy).  
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The fFaecal samples specimens were transported to the Department of Public Health and 
Microbiology Laboratories and processed within 1 h.  
Bacteriological Analysis 
All faecal samples were weighted and diluted 1:10 with normal saline solution. Further serially 
dilutions (10-2-10-9) were made in normal saline solution and small volumes samples (100 l) were 
plated on different media: Brain Heart Infusion Agar (BHA; Biolife, Milan, Italy) for total aerobic 
counts; Azide Maltose Agar (KF; Biolife) to detect enterococci; Chromogenic Coliform Agar 
(CCA; Biolife) to detect Enterobacteriaceae; Rogosa Bios agar to detect lactobacilli (RG; Biolife, 
Milan, Italy), Brain Heart Infusion Agar (BHA; Biolife), Azide Maltose Agar (KF; Biolife), Gram 
Negative Anaerobe Selective Medium (GN; Oxoid, Garbagnate Milanese, Italy) and, Clostridium 
difficile Agar (CLO; bioMèrieux, Rome, Italy), Chromogenic Coliform Agar (CCA; Biolife). 
All plates were incubated at 37°C; for 3 days under aerobic (BHIA,; KF and; CCA plates) were 
incubated , for 24 h under aerobic conditions;  microaerophilic (RG for 3 days under) 
microaerophilic conditions; and anaerobic (GN,; and CLO; RG under) anaerobic conditions. The 
colony counts of the different dilutions were recorded and the microbial counts were reported as 
cfu/g (colony forming unit/ (CFU) per gram of faeces). 
The qualitative analysis was performed by Gram staining and by morphological colorimetric and 
biochemical methods (api Api Strep System; bioMerieuxbioMérieux, Rome, Italy). 
Statistical methods 
All statistical calculations were performed with commercially available software (SPSS for 
Windows release 15.0 SPSS Inc., Chicago, IL, USA). 
Data  are  shown  as median  and  (interquartilic range)   for  continuous  variables  as appropriate. 
The Wilcoxon  test  was  used  to  evaluate  differences  between  paired  samples. All  reported  p 
values  are  two-sided  and  differences  were  considered  to  be significant when p < 0.05. 
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RESULTS 
The first microbial analysis was performed before starting antibiotic therapy with ceftriaxone at 
Time0. In these faecal samples median Median of total bacterial count was 7.80E+09 (2.89E+10), 
Enterobacteriaceae were 2.06E+09 (1.51E+10), eEnterococci were 8.30E+08 (3.05E+09) and 
whereas lLactobacilli were 3.87E+07 (3.04E+07). No clostridia was found. The second microbial 
analysis, performed after 5 days of ceftriaxone administration (T5) showed a significant decreased 
reduction, in comparison with control group at T0, in count of total bacterial count 5.55E+07 
(3.90E+09) (p = 0.003) and in each bacterial group : 5.55E+07 (3.90E+09); in particular 
concentration of : Enterobacteriaceae was 9.75E+06 (6.90E+08), (p =  0.001),  eEnterococci were 
3.03E+03 (1.59E+06) (p = 0.000) and lLactobacilli were 0.00E+01 (1.47E+04) (. p = 0.000). We 
detected Clostridium difficile in 1 infant. At day T20 median of total bacterial count increased with 
bacterial load of was 9.20E+09 (1.36E+10), Enterobacteriaceae were 2.17E+09 (6.06E+09), 
eEnterococci were 3.53E+07 (1.66E+09) and lLactobacilli were 1.46E+07 (2.23E+08). No 
Clostridia was found at T0. However significant differences in gut microflora between T0 and T20 
(total bacterial count   p = 0.228, Enterobacteriaceae p = 0.182, enterococci p = 0.534 and 
lactobacilli p 0.316) were observed. 
The microbial analysis of stool samples after 5 days of ceftriaxone showed a significant reduction in 
total bacterial count (p = 0.003) and in each bacterial group (Enterobacteriaceae p =  0.001, 
Enterococci p = 0.000 and  Lactobacilli p = 0.000). We detected Clostridium difficile in 1 infant.  
We didn’t find significant differences in gut microflora between T0 and T20 (total bacterial count   
p = 0.228, Enterobacteriaceae p = 0.182, Enterococci p = 0.534 and Lactobacilli p 0.316).  
 
DISCUSSION 
Cephalosporins are broad-spectrum antimicrobial agents and they could cause great quantitative and 
qualitative ecological disturbance in normal gut microbiota (VII); this risk is high in particular for 
agents with biliary excretion, like ceftriaxone. Antibiotic administration can cause quantitavite and 
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qualitative ecological disturbances in the normal gut microbiota. They attack specific bacterial 
pathogens but, in the process, they can reduce the number of beneficial bacteria that, particularly in 
infants, is part of the gut-associated lymphatic tissue (VII). These effects vary not only between 
antibiotic class, but also between the specific agent in each class. Ceftriaxone is one of the most 
used antibiotics in paediatric age.In this study we evaluated the modifications that occur in faecal 
microbiota after an antibiotic therapy performed with ceftriaxone in exclusively breast-fed infants. 
Cephalosporins are broad-spectrum antimicrobial agents and they could cause great disturbance in 
intestinal microflora; this risk is high in particular for agents with biliary excretion, like ceftriaxone. 
We decided to analyze modifications induced by ceftriaxone because it is one of the most used 
antibiotics in paediatric age. Studies conducted in adult healthy volunteers showed a significant 
suppression of anaerobic intestinal microflora (IX-X). Another study, conducted in adult patients 
undergoing colon-rectal surgery, demonstrated a suppression significant reduction ofin 
enterobacterial count, with only minor changes in Gram positives aerobic flora and anaerobes (XI). 
As In literature there are only scanty studies concerning the changes inducted in gut microbiota by 
ceftriaxone in pediatric age, in this study we evaluated the modifications in faecal microbiota after 
ceftriaxone therapy in exclusively breast-fed infants. Microbial analysis, performed after 5 of 
ceftriaxone administration showed a decreased count of total bacterial count; in particular there was 
a reduction in Enterobacteriaceae, enterococci and lactobacilli.  These findings are in according 
with those of Borderon et al. who demonstrated a disappearance of Enterobacteriaceae and a 
reduction in concentration of Pseudomonas spp., sStreptococci and Staphilococcus Staphylococcus 
aureus (XII). Another study, conducted by Fujita et al. with only on 3 patients, showed a 
disappearance of bBifidobacteria and Enterobacteriaceae, with a preservation of Streptococcus spp. 
and Staphilococcus Staphylococcus spp. (XIII). In our study the second microbial analysis, 
performed after 5 of ceftriaxone administration showed a decreased count of total bacterial count; in 
particular there was a reduction in concentration of Enterobacteriaceae, Enterococci and 
Lactobacilli.   
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In literature is reported that antibiotics directed against anaerobes (aminopencillins, cephalosporins 
and clindamycin) cause more often diarrhoea (XIV-XV). It is known that Clostridium difficile can 
be responsible for antibiotic (i.e aminopenicillins, cephalosporins and clindamycin) associated 
diarrhoea (XIV-XV-XVI); we found this bacteria bacterium only in 1 patient after ceftriaxone 
therapy with Ceftriaxone, but he it didn’t present modifications in stool frequency (non capisco cosa 
significhi questa frase).  Anyway a limited number of studies has been conducted in infancy to 
evaluate the modifications that occur in gut microflora after an antibiotic therapy and the recovery 
of its original composition. In our patients we didn’t observe any change in stool frequency and 
nobody presented antibiotic associated diarrhoea.  
We decided to analyze only exclusively breast-fed infants because a relationship between human 
milk and infant health had been recorded periodically for thousands of years (XVII). Epidemiologic 
studies found that artificially fed infants are three to ten fold higher risk of disease, in particular 
enteric infections leading to diarrhoea (XVIII-XIX). It is known that there are different mechanism 
by which human milk acts on intestinal mucosa: it accelerates maturation of the gut barrier function, 
it contains bioactive components including IgAs and it attenuate early inappropriate inflammatory 
reactions (XX). Some studies underlined the role of breast-feeding in influencing gut microflora: in 
particular human milk is associated with an higher colonization by Bifidobacteria Bifidobacterium 
spp.  and a lower concentration in bacterial load due to Enterobacteriaceae, Clostridia Clostridium 
spp. and Bacteroides spp. (XXI).   
According to our results, we can hypothesize a protective role of breast-feeding in re-estabilish 
establish normal gut microbiota in a short period of time after antibiotic therapy.  
Some meta-analyses have been completed on the use of probiotics for the prevention of antibiotic 
associated diarrhoea in the general population. The authors concluded that probiotics administration 
significantly reduce the relative risk of AAD in adults (XXII, XXIII). A recent Cochrane Review 
underlines the role of probiotics like Lactobacilli in the prevention of antibiotic associated diarrhoea 
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(AAD) (XXIV) non c’entra tanto con il nostro studio perchè i bambini dello studio non hanno avuto 
diarrea.  
Larger studies, using molecular techniques are warranted not only to study but also to prevent the 
changes that occur in gut microbiota after antibiotic therapy and its consequences. It would be 
interesting to understand if probiotic adimistration during or after antibiotic therapy can speed up 
the re-estabilishment establishment of normal count of lLactobacilli, in order to prevent antibiotic 
associated diarrhoea, in particular in formula-fed infants.  
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